The heart in systemic lupus erythematosus: Introduction

Current Problems in Cardiology

Volumn 24, Issue 1, 1999, Pages 6-56

  Roberts, William Clifford ^{a,b,c,d,e,f,g,h}   High, Shyla Thomas ^a,i,j  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b Baylor Cardiovascular Institute   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BOSTON MEDICAL CENTER   (United States)

^f JOHNS HOPKINS HOSPITAL   (United States)

^g National Heart Institute   (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^j TEXAS TECH UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYCHLOROQUINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PREDNISONE; TRIACYLGLYCEROL; WARFARIN; GLUCOCORTICOID;

ATHEROSCLEROTIC PLAQUE; AUTOPSY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORTICOSTEROID THERAPY; ELECTROCARDIOGRAPHY; ENDOCARDITIS; HEART ABSCESS; HEART DISEASE; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HUMAN; MYOCARDITIS; PERICARDITIS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE; ADOLESCENT; ADULT; ANGIOCARDIOGRAPHY; CHILD; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART; HEART MUSCLE; IMMUNOLOGY; MALE; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREGNANCY; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; CHILD; CORONARY ANGIOGRAPHY; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEART; HEART DISEASES; HUMANS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIUM; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 0032619960     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (117)

1. Humphreys EM. The cardiac lesions of acute disseminated lupus erythematosus. Ann Intern Med 1948;28:12-4.
2. Shearn MA. The heart in systemic lupus erythematosus. Am Heart J 1959;58:452-66.
3. Kong TQ, Kellum RE, Haserick JR. Clinical diagnosis of cardiac involvement in systemic lupus erythematosus: a correlation of clinical and autopsy findings in thirty patients. Circulation 1962;26:7-11.
4. Hejtmancik MR, Wright JC, Quint R, Jennings FL. The cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1964;68:119-30.
5. Marks AD. The cardiovascular manifestations of systemic lupus erythematosus. Am J Med Sci 1972;264:254-65.
6. Ansari A, Larson PH, Bates HD. Cardiovascular manifestations of systemic lupus erythematosus: current perspective. Progress Cardiovasc Dis 1985;27:421-34.
7. Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1985;110:1257-65.
8. Mandell BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 1987;17:126-41.
9. Cujec B, Sibley J, Haga M. Cardiac abnormalities in patients with systemic lupus erythematosus. Can J Cardiol 1991;7:343-9.
10. De Inocencio J, Lovell DJ. Cardiac function in systemic lupus erythematosus. Rheumatology 1994;21:2147-56.
11. Boumpas DT, Austin HA III, Fessler BJ, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts - part 1: renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med 1995; 122:940-50.
12. Boumpas DT, Fessler BJ, Austin HA III, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts - part 2: dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann Intern Med 1995;123:42-53.
13. Biett T. Abrege pratique des maladies de la peau, d'apres les auteurs les plus estimes, et surtout d'apres des documens puises dans les lecanc cliniques de le docteur Biett. Paris: Bechet; 1828. p. 526.
14. Kaposi MK. Neue beitrage zur Kenntniss des lupus erythematosus. Arch Dermal U Syph 1872;4:36-78.
15. Osler W. On the visceral complications of erythema exudativum multiforme. Am J Med Sci 1895;110:629-46.
16. Osler W. The visceral lesions of the erythema group. Br J Dermatol 1900;12:227-45.
17. Osler W. On the visceral manifestations of the erythema group of skin diseases. Tr Assoc Am Physicians 1903;18:599-624.
18. Tumulty PA, Harvey AM. The clinical course of disseminated lupus erythematosus: an evaluation of Osler's contribution. Bull Johns Hopkins Hosp 1949;85:47-73.
19. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 1924;33:701-37.
20. Keefer CS, Felty AR. Acute disseminated lupus erythematosus: report of three fatal cases. Johns Hopkins Hosp Bull 1924;35:294-304.
21. Friedberg CK, Gross L, Wallach K. Nonbacterial thrombotic endocarditis associated with prolonged fever, arthritis, inflammation of serous membranes and widespread vascular lesions. Arch Intern Med 1936;58:641-61.
22. Gross L. The cardiac lesions in Libman-Sacks disease with a consideration of its relationship to acute diffuse lupus erythematosus. Am J Pathol 1940;16:375-419.
23. Baehr G, Klemperer P, Schifrin A. A diffuse disease of the peripheral circulation (usually associated with lupus erythematosus and endocarditis). Tr Assoc Am Physicians 1935;50:139-55.
24. Klemperer P, Pollack AD, Baehr G. Pathology of disseminated lupus erythematosus. Arch Path 1941;32:569-631.
25. Klemperer P, Pollack AD, Baehr G. Diffuse collagen disease: acute disseminated lupus erythematosus and diffuse scleroderma. JAMA 1942;119:331-2.
26. Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: a study of 36 necropsy patients. Am J Med 1975;58:243-64.
27. Hargraves MM, Richmond H, Morton R. Presentation of two bone marrow elements: the "Tart" cell and the "L.E." cell. Proc Staff Meet Mayo Clin 1948;23:25-8.
28. Kendall EC. Some observations on hormone of adrenal cortex designated compound E. Proc Staff Meet Mayo Clin 1948;24:298-301.
29. Haserick JR, Corcoran AC, Dustan H. ACTH and cortisone in acute crisis of systemic lupus erythematosus. JAMA 1951;146:643-5.
30. Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine 1954;33:291-437.
31. Rich AR, Gregory JE. Experimental anaphylactic lesions of coronary arteries of "sclerotic" type, commonly associated with rheumatic fever and disseminated lupus erythematosus. Bull Johns Hopkins Hosp 1947;81:312-24.
32. Ben-Asher S. Recurrent acute lupus erythematosus disseminatus: report of a case which has survived 23 years after the onset of systemic manifestations. Ann Intern Med 1951;3:243-8.
33. Taubenhaus M, Eisenstein B, Pick A. Cardiovascular manifestations of collagen diseases. Circulation 1955;12:903-20.
34. Aravanis C, Toutouzas P, Yatzidis I. Fatal myocardial infarction in lupus erythematosus: report of a case of a young female patient. Vasc Dis 1964;1:258-60.
35. Roberts WC, Roberts JD. The floating heart or the heart too fat to sink: analysis of 55 necropsy patients. Am J Cardiol 1983;52:1286-9.
36. Shirani J, Berezowski K, Roberts WC. Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage. Am J Cardiol 1995;76:414-8.
37. Lucena GE, Bennett WM, Pierre RV. "Dewlap." A corticosteroid-induced episternal fatty tumor. N Engl J Med 1966;275:834-5.
38. Price JE Jr, Rigler LG. Widening of the mediastinum resulting from fat accumulation. Radiology 1970;96:497-500.
39. Isner JM, Carter BL, Roberts WC, Bankoff MS. Subepicardial adipose tissue producing echocardiographic appearance of pericardial effusion: documentation by computer tomography and necropsy. Am J Cardiol 1983;51:565-9.
40. Budman DR, Steinberg AD. Hypertension and renal disease in systemic lupus erythematosus. Arch Intern Med 1976;136:1003-7.
41. Mantero F, Boscaro M. Glucocorticoid-dependent hypertension. J Steroid Biochem Mol Biol 1992;43:409-13.
42. Petri M, Spence D, Bone LR, Hochberg MC. Coronary artery disease risk factors in the Johns Hopkins Lupus cohort: prevalence, recognition by patients, and preventive practices. Medicine 1992;71:291-303.
43. Walser M, Seldin DW, Burnett CH. Blood volume and extracellular fluid volume during administration of ACTH and cortisone. Am J Med 1955;18:454-61.
44. Skanse B, von Studnitz W, Skoog N. The effect of corticotropin and cortisone on serum lipids and lipoproteins. Acta Endocrinol 1959;31:442-50.
45. Etranger WH, Goldberg AP, Applebaum-Bowden D, Hazzard WR. Dyslipoproteinemia in systemic lupus erythematosus: effect of corticosteroids. Am J Med 1987;83:503-7.
46. Etheridge EM, Hoch-Legeti C. Lipid deposition in aortas in younger age groups following cortisone and adrenocorticotrophic hormone. Am J Pathol 1952;28:315-9.
47. Kalbak K. Incidence of arteriosclerosis in patients with rheumatoid arthritis receiving long-term corticosteroid therapy. Ann Rheum Dis 1972;31:196-200.
48. Haider YS, Roberts WC. Coronary arterial disease in systemic lupus erythematosus: quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am J Med 1981;70:775-81.
49. Fukumoto S, Tsumagari T, Kinjo M, Tanaka K. Coronary atherosclerosis in patients with systemic lupus erythematosus at autopsy. Acta Pathol Jpn 1987;37:1-9.
50. Homey CJ, Liberthson RR, Fallon JT, Gross S, Miller LM. Ischemic heart disease in systemic lupus erythematosus in the young patient: report of six cases. Am J Cardiol 1982;49:478-84.
51. Spiera H, Rothenberg RR. Myocardial infarction in four young patients with SLE. J Rheum 1983;10:464-6.
52. Elfawal MA. Sudden cardiac ischaemic death associated with systemic lupus erythematosus. Med Sci Law 1994;34:80-3.
53. Tumulty PA. The clinical course of systemic lupus erythematosus. JAMA 1954; 156:947-53.
54. Copeland GD, von Capeller D, Stern TN. Systemic lupus erythematosus: a clinical report of 47 cases with pathologic findings in 18. Am J Med Sci 1958;236:318-28.
55. Brigden W, Bywaters EGL, Lessof MH, Ross IP. The heart in systemic lupus erythematosus. Br Heart J 1960;22:1-16.
56. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine 1971;50:85-95.
57. Urowitz MB, Bookman AAM, Koehler BE, Gordon DA, Smythe HA, Ogtyzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976;60:221-5.
58. Baker SB, Rovira JR, Campion EW, Mills JA. Late onset systemic lupus erythematosus. Am J Med 1979;66:727-32.
59. Wallace DJ, Podell T, Weiner J, Klinenberg JR, Forouzesh S, Dubois E. Systemic lupus erythematosus - survival patterns: experience with 609 patients. JAMA 1981;245:934-8.
60. Rosner S, Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, et al. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 1982;25:612-7.
61. Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: a prognostic study of patients from a defined population. Medicine 1989;68:141-50.
62. Sturfelt G, Eskilsson J, Nived O, Truedsson L, Valind S. Cardiovascular disease in systemic lupus erythematosus: a study of 75 patients from a defined population. Medicine 1992;71:216-23.
63. Cohen MG, Li EK. Mortality in systemic lupus erythematosus: active disease is the most important factor. Aust NZJ Med 1992;22:5-8.
64. Kawai S, Mizushima Y, Kaburaki J. Increased serum lipoprotein(a) levels in systemic lupus erythematosus with myocardial and cerebral infarctions. J Rheum 1995;22:1210-1.
65. Petri M, Lakatta C, Magder L, Goldman D. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 1994;96:254-9.
66. Lehman TJA, Palmeri ST, Hastings C, Klippel JH, Plotz PH. Bacterial endocarditis complicating systemic lupus erythematosus. J Rheum 1983;10:655-8.
67. Murray FT, Fulehan DS, Cornwall CS, Finals RS. Acute mitral regurgitation from ruptured chordae tendineae in systemic lupus erythematosus. J Rheum 1975;2:454-9.
68. Bulkley BH, Roberts WC. Systemic lupus erythematosus as a cause of severe mitral regurgitation: new problem in an old disease. Am J Cardiol 1975;35:305-8.
69. Kalangos A, Panos A, Sezerman O. Mitral valve repair in lupus valvulitis - report of a case and review of the literature. J Heart Valve Dis 1995;4:202-7.
70. Dajee H, Hurley EJ, Szarnicki RJ. Cardiac valve replacement in systemic lupus erythematosus. Thorac Cardiovasc Surg 1983;85:718-26.
71. Straaton KV, Chatham WW, Reveille JD, Koopman WJ, Smith SH. Clinically significant valvular heart disease in systemic lupus erythematosus. Am J Med 1988;85:645-50.
72. Alameddine AK, Schoen FJ, Yanagi H, Couper GS, Collins JJ, Cohn LH. Aortic or mitral valve replacement in systemic lupus erythematosus. Am J Cardiol 1992;70:955-6.
73. Shulman HJ, Christian CL. Aortic insufficiency in systemic lupus erythematosus. Arthritis Rheum 1969;12:138-46.
74. Bernhard GC, Lange RL, Hensley GT. Aortic disease with valvular insufficiency as the principal manifestations of systemic lupus erythematosus. Ann Intern Med 1969;71:81-7.
75. Benotti JR, Sataline LR, Sloss LJ, Cohn LH. Aortic and mitral insufficiency complicating fulminant systemic lupus erythematosus. Chest 1984;86:140-3.
76. Chartash EK, Lans DM, Paget SA, Qamar T, Lockshin MD. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med 1989;86:407-11.
77. Paget SA, Bulkley BH, Grauer LE, Seningen R. Mitral valve disease of systemic lupus erythematosus: a cause of severe congestive heart failure reversed by valve replacement. Am J Med 1975;59:134-9.
78. Vaughton KC, Walker DR, Sturridge MF. Mitral valve replacement for mitral stenosis caused by Libman-Sacks endocarditis. Br Heart J 1979;41:730-3.
79. Pritzker MR, Ernst JD, Caudill C, Wilson CS, Weaver WF, Edwards JE. Acquired aortic stenosis in systemic lupus erythematosus. Ann Intern Med 1980;93:434-6.
80. Lerman BB, Thomas LC, Abrams GD, Pitt B. Aortic stenosis associated with systemic lupus erythematosus. Am J Med 1982;72:707-10.
81. Zimmerman B III, Lally EV, Sharma SC, Schoen FJ, Kaplan SR. Severe aortic stenosis in systemic lupus erythematosus and mucopolysaccharidosis type II (Hunter's syndrome). Clin Cardiol 1988;11:723-5.
82. Fox IS, Spence AM, Wheelis RF, Healey LA. Cerebral embolism in Libman-Sacks endocarditis. Neurology 1980;30:487-91.
83. Elias M, Eldor A. Thromboembolism in patients with the "lupus"-type circulating anticoagulant. Arch Intern Med 1984;144:510-5.
84. Gorelick PB, Rusinowitz MS, Tiku M, McDonald LW, Robbins L. Embolic stroke complicating systemic lupus erythematosus. Arch Neurol 1985;42:813-5.
85. Myerowitz PD, Michaelis LL, McIntosh CL. Mitral valve replacement for mitral regurgitation due to Libman-Sacks endocarditis. J Thorac Cardiovasc Surg 1974;67:869-74.
86. Laufer J, Frand M, Milo S. Valve replacement for severe tricuspid regurgitation caused by Libman-Sacks endocarditis. Br Heart J 1982;48:294-7.
87. Gordon RJ, Weilbaecher D, Davy SM, Safi JH, Quinones MA, DeFelice CA, et al. Valvulitis involving a bioprosthetic valve in a patient with systemic lupus erythematosus. J Am Soc Echocardiogr 1996;9:104-7.
88. Kahl LE. The spectrum of pericardial tamponade in systemic lupus erythematosus. Arthritis Rheum 1992;35:1343-9.
89. James TN, Rupe CE, Monto RW. Pathology of the cardiac conduction system in systemic lupus erythematosus. Ann Intern Med 1965;63:402-10.
90. Klinkhoff AV, Thompson CR, Reid GD, Tomlinson CW. M-mode and two-dimensional echocardiographic abnormalities in systemic lupus erythematosus. JAMA 1985;253:3273-7.
91. Galve E, Candell-Riera J, Pigrau C, Permanyer-Miralda G, Garcia-Del-Castillo H, Soler-Soler J. Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 1988;319:817-23.
92. Crozier IG, Li E, Milne MJ, Nicholls MG. Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol 1990;65:1145-8.
93. Khamashta MA, Cervera R, Asherson RA, Font J, Gil A, Coltart DJ, et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990;335:1541-4.
94. Nihoyannopoulos P, Gomez PM, Joshi J, Loizou S, Walport MJ, Oakley CM. Cardiac abnormalities in systemic lupus erythematosus: association with raised anticardiolipin antibodies. Circulation 1990;82:369-75.
95. Leung WH, Wong K-L, Lau C-P, Wong C-K, Cheng C-H. Cardiac abnormalities in systemic lupus erythematosus: a prospective M-mode, cross-sectional and Doppler echocardiographic study. Int J Cardiol 1990;27:367-75.
96. Leung W-H, Wong K-L, Lau C-P, Wong C-K, Liu H-W. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 1990;89:411-9.
97. Cervera R, Font J, Paré C, Azqueta M, Pérez-Villa F, Löpez-Soto A, et al. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 1992;51:156-9.
98. Ong ML, Veerapen K, Chambers JB, Lim MN, Manivasagar M, Wang F. Cardiac abnormalities in systemic lupus erythematosus: prevalence and relationship to disease activity. Int J Cardiol 1992;34:69-74.
99. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996;335:1424-30.
100. Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 1992;20:1127-34.
101. Hosenpud JD, Montanaro A, Hart MV, Haines JE, Specht HD, Bennett RM, et al. Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus. Am J Med 1984;77:286-92.
102. Been M, Thomson BJ, Smith MA, Ridgway JP, Douglas RHB, Been M, et al. Myocardial involvement in systemic lupus erythematosus detected by magnetic resonance imaging. Eur Heart J 1988;9:1250-6.
103. Plant RK, Steven RA. Complete A-V block in a fetus: case report. Am Heart J 1945;30:615-8.
104. Chameides L, Truex RC, Vetter V, Rashkind WJ, Galioto FM, Noonan JA. Association of maternal systemic lupus erythematosus with congenital complete heart block. N Engl J Med 1977;297:1204-7.
105. McCue CM, Mantakas ME, Tingelstad JB, Ruddy S. Congenital heart block in newborns of mothers with connective tissue disease. Circulation 1977;56:82-90.
106. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994;120:544-51.
107. Goble MM, Dick M II, McCune WJ, Ellsworth J, Sullivan DB, Stern AM. Atrioventricular conduction in children of women with systemic lupus erythematosus. Am J Cardiol 1993;71:94-8.
108. Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med 1983;309:209-12.
109. Boyon JP, Winchester R. Congenital complete heart block: a human model of passively acquired autoimmune injury. Arthritis Rheum 1990;33:609-14.
110. Silverman E, Mamula M, Hardin JA, Laxer R. Importance of the immune response to the Ro/La particle in the development of congenital heart block and neonatal lupus erythematosus. J Rheumatol 1991;18:120-4.
111. Press J, Uziel Y, Laxer RM, Luy L, Hamilton RM, Silverman ED. Long-term outcome of mothers of children with complete congenital heart block. Am J Med 1966;100:328-32.
112. Asherson RA, Oakley CM. Pulmonary hypertension and systemic lupus erythematosus. J Rheumatol 1986;13:1-5.
113. Asherson RA, Higenbottam TW, Xuan ATD, Khamashta MA, Hughes GRV. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 1990;17:1292-8.
114. Simonson JS, Schiller NB, Petri M, Hellmann DB. Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1989;16:918-25.
115. Winslow TM, Ossipov MA, Fazio GP, Simonson JS, Redberg RF, Schiller NB. Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J 1995;129:510-5.
116. Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants. Ann Intern Med 1997;127:177-85.
117. Bick RL, Baker WF Jr. The antiphospholipid and thrombosis syndromes. Med Clin North Am 1994;78:667-84.